Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: Defective rejoining of radioinduced dna strand breaks in lymphocytes of breast cancer patients

Therapeutic exposure to ionising radiation reveals inter‐individual variations in normal tissue responses. To examine whether a defect in DNA repair capacity might be involved in such hypersensitive phenotypes, we analysed, using the alkaline comet assay, the response as a function of time to in vitro irradiation at 5 Gy of lymphocytes from 17 breast cancer and 9 Hodgkin's disease patients who developed severe reactions to radiotherapy in comparison with 22 patients with “average” reactions and 24 healthy donors. A difference between breast cancer over‐reactors and both patients with normal reactions and healthy donors was observed 30 and 60 min after exposure. A subgroup of breast cancer over‐reactors (7/17) reproducibly demonstrated increased levels of residual damage. When the kinetic analyses were prolonged to 120 min, results were in favour of delayed kinetics of rejoining in these patients. Among Hodgkin's disease over‐reactors, only one patient showed defective repair. Interestingly, all patients with the most severe complications (grade 4 RTOG/EORTC), i.e., 5 breast cancer and 1 Hodgkin's disease, showed impaired rejoining. Our results suggest that impairment in DNA strand break processing may be associated, in specific subgroups of breast cancer patients, with an individual risk of major toxicity of radiation therapy. Thus, the alkaline comet assay appears to be useful for documenting the DNA repair phenotype in cancer patients. Int. J. Cancer 83:83–90, 1999. © 1999 Wiley‐Liss, Inc.

[1]  M. Swift,et al.  Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. , 1998, International journal of radiation oncology, biology, physics.

[2]  M. Schlumberger,et al.  Impaired DNA repair as assessed by the "comet" assay in patients with thyroid tumors after a history of radiation therapy: a preliminary study. , 1998, International journal of radiation oncology, biology, physics.

[3]  E. Sage,et al.  Use of the alkaline comet assay to detect DNA repair deficiencies in human fibroblasts exposed to UVC, UVB, UVA and gamma-rays. , 1996, International journal of radiation biology.

[4]  T. Stankovic,et al.  Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. , 1997, British Journal of Cancer.

[5]  R E Durand,et al.  Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. , 1990, Radiation research.

[6]  R. Cowan,et al.  Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. , 1995, International journal of radiation biology.

[7]  H. Magdelenat,et al.  Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II. Alteration of DNA repair and chromosome radiosensitivity. , 1990, Mutation research.

[8]  U. Plappert,et al.  Does physical activity induce DNA damage? , 1994, Mutagenesis.

[9]  M. Lavin,et al.  Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  S. Tucker,et al.  Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. , 1995, International journal of radiation oncology, biology, physics.

[11]  C. Lewis,et al.  Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  R. Cowan,et al.  A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. , 1995, International journal of radiation biology.

[13]  M. Green,et al.  UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and xeroderma pigmentosum donors in the comet assay: a potential diagnostic technique. , 1992, Mutation research.

[14]  S M Bentzen,et al.  Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  E. Moustacchi,et al.  The comet assay as a repair test for prenatal diagnosis of Xeroderma pigmentosum and trichothiodystrophy. , 1997, The Journal of investigative dermatology.

[16]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International journal of radiation oncology, biology, physics.

[17]  S. Seal,et al.  Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. , 1998, British Journal of Cancer.

[18]  R. Parshad,et al.  Deficient DNA repair capacity, a predisposing factor in breast cancer. , 1996, British Journal of Cancer.

[19]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[20]  John R Yates,et al.  The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response , 1998, Cell.

[21]  D. McCurdy,et al.  Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. , 1997, Radiation research.

[22]  R. Patel,et al.  DNA repair proficiency in breast cancer patients and their first‐degree relatives , 1997, International journal of cancer.

[23]  A. Hart,et al.  Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. , 1998, International journal of radiation biology.

[24]  P. J. van der Spek,et al.  Nucleotide excision repair syndromes: molecular basis and clinical symptoms. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[25]  M. Green,et al.  The single cell gel electrophoresis assay (comet assay): a European review. , 1993, Mutation research.

[26]  T. Jorgensen,et al.  The ATM gene and the radiobiology of ataxia-telangiectasia. , 1996, International journal of radiation biology.

[27]  M. Swift,et al.  Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.

[28]  J. Lebesque,et al.  Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. , 1993, International journal of radiation biology.

[29]  Cristina González,et al.  Assessment of DNA damage in leukocytes from infected and malnourished children by single cell gel electrophoresis/comet assay. , 1995, Mutation research.

[30]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[31]  N. Bundred,et al.  Genetic predisposition to breast cancer. , 1998, The British journal of surgery.

[32]  M. Barcellos-Hoff,et al.  How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. , 1998, Radiation research.

[33]  M. Green,et al.  Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance. , 1990, Mutagenesis.

[34]  W. Kimberling,et al.  Genetic predisposition to breast cancer , 1984, Cancer.